Business Description
AXIM Biotechnologies Inc
NAICS : 325412
SIC : 2834
ISIN : US05463V1008
Total Employee Number:
7Description
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -3.23 | |||||
Debt-to-Equity | -0.72 | |||||
Debt-to-EBITDA | 17.31 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -37 | |||||
Beneish M-Score | -4.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 57.2 | |||||
3-Year EPS without NRI Growth Rate | 49.7 | |||||
3-Year FCF Growth Rate | 46 | |||||
3-Year Book Growth Rate | -24.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.98 | |||||
9-Day RSI | 46.11 | |||||
14-Day RSI | 45.4 | |||||
3-1 Month Momentum % | -10.65 | |||||
6-1 Month Momentum % | -65.33 | |||||
12-1 Month Momentum % | -11.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.2 | |||||
Shareholder Yield % | -70.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -962.86 | |||||
OCF Margin % | -962.86 | |||||
ROE % | Neg. Equity | |||||
ROA % | 3.96 | |||||
ROIC % | -3.57 | |||||
3-Year ROIIC % | 291.45 | |||||
ROC (Joel Greenblatt) % | 89.52 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | 41.25 | |||||
EV-to-EBITDA | 20.81 | |||||
EV-to-Revenue | 129.64 | |||||
EV-to-FCF | -13.46 | |||||
Earnings Yield (Greenblatt) % | 2.42 | |||||
FCF Yield % | -43.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AXIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AXIM Biotechnologies Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.07 | ||
| EPS (TTM) ($) | - | ||
| Beta | 0.0036 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.42 | ||
| Volatility % | 168.22 | ||
| 14-Day RSI | 45.4 | ||
| 14-Day ATR ($) | 0.000645 | ||
| 20-Day SMA ($) | 0.004723 | ||
| 12-1 Month Momentum % | -11.86 | ||
| 52-Week Range ($) | 0.002 - 0.0288 | ||
| Shares Outstanding (Mil) | 340.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AXIM Biotechnologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AXIM Biotechnologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 138 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 52 days | ||
| General meeting for 2025 | 2026-06-29 | In 1 day | ||
| First quarter earnings results for 2026 | 2026-05-18 | 0.01 (-0.35%) | ||
| Annual report for 2025 | 2026-04-15 | 0.01 (-1.59%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.01 (+8.84%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 0.01 (-1.96%) | ||
| First quarter earnings results for 2025 | 2025-05-19 | 0.01 (+13.49%) | ||
| Annual report for 2024 | 2025-04-15 | 0.00 (-12.00%) | ||
| Third quarter earnings results for 2024 | 2024-11-19 | 0.00 (-7.54%) |
Show
Entries
AXIM Biotechnologies Inc Frequently Asked Questions
What is AXIM Biotechnologies Inc(AXIM)'s stock price today?
The current price of AXIM is $0.00. The 52 week high of AXIM is $0.03 and 52 week low is $0.00.
When is next earnings date of AXIM Biotechnologies Inc(AXIM)?
The next earnings date of AXIM Biotechnologies Inc(AXIM) is 2026-08-19 Est..
Does AXIM Biotechnologies Inc(AXIM) pay dividends? If so, how much?
AXIM Biotechnologies Inc(AXIM) does not pay dividend.
Guru Commentaries on OTCPK:AXIM
No articles.
Press Release
Articles on AXIM Biotechnologies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers